by Steve Michel | Dec 19, 2018 | Press Releases
Sutro Achieves $10 Million Milestone Payment from Celgene Sutro develops successful spray drying technology marking a major advancement in commercial-scale manufacturing capabilities SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 — Sutro Biopharma, Inc. (NASDAQ:...
by Dave McCollum | Aug 10, 2017 | Press Releases
Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs Will Rapidly Advance Promising Drug Candidates to the Clinic SOUTH SAN FRANCISCO, Aug. 10, 2017 – Sutro Biopharma today announced it is refocusing its 2014 immuno-oncology...
by Corporate Communications | Sep 7, 2016 | Press Releases
Sutro Marks Important Progress — Receives Two Milestone Payments from Celgene SAN FRANCISCO, Sept. 7, 2016 – Sutro Biopharma Inc. today announced that it has received two milestone payments from drug discovery and development partner Celgene Corporation...
by Corporate Communications | Oct 23, 2014 | Press Releases
Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to Acquire Agreement Deal expands Immuno-Oncology Product Discovery and Development Program and Aims to Accelerate Development of Oncology Therapeutics with Compelling Patient...
by Corporate Communications | Dec 18, 2012 | Press Releases
Sutro Biopharma Collaborates with Celgene Corporation to Design and Develop Next-Generation Antibody Drug Conjugates and Bispecific Antibodies SAN FRANCISCO, Dec. 18, 2012 – Sutro Biopharma today announced a collaboration with Celgene Corporation to design and...
